![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
用T细胞激活剂作为癌症免疫疗法治疗患者的传染性并发症,来自REISAMIC注册表的描述性研究
Thomas Hueso1,2, Justin Cagnat1, Kaïssa Ouali1
1Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.
概括
感染是接受T细胞参与剂的患者的风险,特别是那些患有血液病或先前治疗的患者. 然而,在本研究中,皮质类固醇和托西利祖马布并没有增加感染率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 参与T细胞的药物代表了癌症治疗的重大进展.
- 了解传染性并发症对于管理这些新型治疗的患者至关重要.
研究的目的:
- 为了调查感染性并发症的发生率,治疗T细胞参与者患者.
- 确定与这些感染相关的风险因素.
主要方法:
- 对181名接受T细胞诱导治疗的患者进行了回顾性分析.
- 收集有关患者人口统计,疾病类型,治疗史和传染病事件的数据.
主要成果:
- 在患有血液性恶性瘤的患者和重度预治疗的患者中观察到传染性并发症.
- 由于感染的死亡率为2.8%.
- 同时使用皮质类固醇或托西利祖马布并没有显著改变感染发病率.
结论:
- T细胞诱导疗法与传染性风险有关,特别是在脆弱的患者群体中.
- 风险分层和监测对于接受T细胞吸引治疗的患者至关重要.
- 进一步的研究可能会探索针对这一群体感染的特定预防策略.
关键词:
这就是为什么BCMABCMABCMA.双特异性抗体 双特异性抗体CD20 CD20 是一个CD20 CD20 是一个CD20.在 DLL3 中,你会看到 DLL3 文件.感染 感染 感染这些T细胞参与者.更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
392
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.2K
相关概念视频
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
01:27Cytotoxic T Cells-mediated Immune Response
798
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
798